Title: Serum Magnesium Levels in Type 2 Diabetes Mellitus and its Association with the Microvascular Complications
Authors: Dr Sajal Kamat (MBBS MD), Dr Dnyanesh Morkar (MBBS, MD, DNB, FGSI), Dr Siddharth Madnani (MBBS MD)
DOI: https://dx.doi.org/10.18535/jmscr/v5i2.137
Abstract
Background and Objectives: Hypomagnesemia has been associated with type 2 diabetic mellitus. This study aimed to evaluate serum magnesium levels in patients with type 2 DM and study its association with the microvascular complications.
Methodology: The present one year hospital based cross-sectional study was done on 150 patients with type 2 diabetes mellitus from January 2014 to December 2014 in Department of Medicine, KLES Dr. Prabhakar Kore Hospital and Medical Research Centre, Belgaum. Serum magnesium levels were assessed in all the diabetic patients and they were also tested for presence of microvascular complications.
Results: In the present study majority of the patients (71.33%) were males and male to female ratio was 2.48:1. The commonest age group was > 60 years (50%). The duration of diabetes in 45.33% of the patients was between 6 to 10 years. HbA1c levels were ≥8.5% in 51.33% of the patients. Serum magnesium levels were < 1.8 mg/dL in 41.33% of the patients. Microvascular complications were present in 54.67% of the patients and diabetic retinopathy was present in 32%. Diabetic nephropathy and diabetic peripheral neuropathy were seen in 36% of the patients each. Also association was found between serum magnesium levels glycaemic control and duration of diabetes (p<0.050).
Conclusion: Hypomagnesemia is widely prevalent in patients with type 2 diabetes mellitus and a major risk factor for the development microvascular complications
Keywords : Hypomagnesemia; Diabeticnephropathy; Diabeticneuropathy; Diabeticretinopathy; Microva-scular complications ; Type 2 Diabetes Mellitus.
References
1. Fauci AS, Kasper DS, Longo DL, Braunwald E, Hauser SL, Jameson JL, et al. Harrison’s principles of internal medicine. United States; McGraw Hill: 2008.
2. Sarkar A, Dash S, Barik BK, Muttigi MS, Kedage V, Shetty JK, et al. Copper and Ceruloplasmin levels in relation to total thiols and GST in type 2 diabetes mellitus patients. Ind J ClinBiochem 2010;25:74-6.
3. Koda-Kimble MA, Carlisle BA. Diabetes mellitus. In: Young LY, Koda-Kimble MA, Kradjan WA, Guglielmo BJ, eds. Applied therapeutics: the clinical use of drugs. 6th ed., Vancouver (WA): Applied therapeutics 1995; 48:481-5.
4. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-53
5. Mohan V, Sandeep S, Deepa R, Shah B, Varghese C. Epidemiology of type 2 diabetes: Indian scenario. Indian J Med Res 2007;125:217-30.
6. Dasgupta A, Sarma D, Saikia UK. Hypomagnesemia in type 2 diabetesmellitus. Indian J EndocrMetab 2012;16:1000-3
7. Huizinga MM, Rothman RL. Addressing the diabetespandemic: A comprehensive approach. Indian J Med Res 2006;124:481-4.
8. Puri M, Gujaral M, Nayyar SB. Comparative study of serum zinc, magnesium and copper levels among patients of type 2 diabetes mellitus with and without microangiopathic complicat-ions. Innovative Journal of Medical and Health Science 2013;3(6)L274-8.
9. US Department of Agriculture. Agricultural Research Service: USDA National Nutrient Database for standard reference, Release 16, 2003: Nutrient Data Laboratory Home Page http://www.nal.usda.gov/fnic/food comp.
10. Hans CP, Sialy R, Bansal DD. Magnesium deficiency and diabetes mellitus. CurrSci 2002;83(12):1456-63.
11. Elamin A, Tuvemo T. Magnesium and insulindependent diabetes mellitus. Diabetes Res ClinPract 1990;10:203-9.
12. Kao WHL, Folsom AR, Nieto FJ, Watson RL, Brancati, FL. Serum and dietary magnesium and the risk for type 2 diabetes: The Atherosclerosis Risk in Communities Study. Arch Intern Med 1999;159:2151-9.
13. Grafton G, Baxter MA, Sheppard MC. Effects of magnesium on sodium dependant inositol transport. Diabetes 1992;41:35-9.
14. Kahn R, Weir G, King GL, Moses HC, Smith RJ, Jacobson AM. Joslin’s diabetes mellitus. 14th ed., New Delhi: Lippincot Williams & Wilkins; 2004.
15. Swain RP, Subudhi BB, MahapatraAK, Bolapreddi V. Bridging Between Disease, Prevalence and Treatment of Diabetes Mellitus: A Review. Int J Pharm Tech Res 2015;7(2):212-28.
16. Mohan V, Sandeep S, Deepa R, Shah B, Varghese C. Epidemiology of type 2 diabetes: Indian scenario. Indian J Med Res 2007;125:217-30.